Sep 16, 2020 / 03:45PM GMT
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive Director
This is Matthew Harrison. I'm one of the biotech analysts here at Morgan Stanley. Very pleased to have Amgen with me for the next session.
Quickly, before we get started, I need to read a brief disclaimer. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of...
(technical difficulty)
Please disconnect and -- separately.
For important disclosures, visit the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley representatives.
So I'm very pleased to have Bob Bradway, the CEO; Peter Griffith, the CFO; and Arvind Sood from IR. And Bob, I'm going to turn it over to you to make some opening comments, and then we'll get into Q&A.
Robert A. Bradway - Amgen Inc. - Chairman, CEO & President
Okay, Matthew. Well, first
Amgen Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers